SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-039284
Filing Date
2019-08-13
Accepted
2019-08-13 06:03:49
Documents
47
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526318_10q.htm 10-Q 404049
2 EXHIBIT 31.1 tv526318_ex31-1.htm EX-31.1 7339
3 EXHIBIT 31.2 tv526318_ex31-2.htm EX-31.2 7334
4 EXHIBIT 32.1 tv526318_ex32-1.htm EX-32.1 3925
5 EXHIBIT 32.2 tv526318_ex32-2.htm EX-32.2 4079
  Complete submission text file 0001144204-19-039284.txt   2395094

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20190630.xml EX-101.INS 425179
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20190630.xsd EX-101.SCH 27116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20190630_cal.xml EX-101.CAL 27402
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20190630_def.xml EX-101.DEF 81161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20190630_lab.xml EX-101.LAB 205180
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20190630_pre.xml EX-101.PRE 172307
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 191018141
SIC: 2836 Biological Products, (No Diagnostic Substances)